ABVC BIOPHARMA INC's ticker is ABVC and the CUSIP is 00091F106. A total of 10 filers reported holding ABVC BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $71,033 | -19.1% | 139,282 | 0.0% | 0.00% | – |
| Q1 2023 | $87,775 | +100790.8% | 139,282 | 0.0% | 0.00% | – |
| Q4 2022 | $87 | -99.9% | 139,282 | -0.3% | 0.00% | – |
| Q3 2022 | $122,000 | +134.6% | 139,653 | +179.8% | 0.00% | – |
| Q2 2022 | $52,000 | -61.8% | 49,915 | 0.0% | 0.00% | – |
| Q1 2022 | $136,000 | -19.5% | 49,915 | 0.0% | 0.00% | – |
| Q4 2021 | $169,000 | +47.0% | 49,915 | 0.0% | 0.00% | – |
| Q3 2021 | $115,000 | – | 49,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,092,745 | $1,158,000 | 0.02% |
| VANGUARD GROUP INC | 375,142 | $398,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 49,915 | $52,000 | 0.00% |
| BlackRock Inc. | 39,042 | $41,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,997 | $6,000 | 0.00% |